Program Office Publications
The programs funded through the NCI Alliance for Nanotechnology in Cancer have made significant progress in advancing cancer nanotechnology research. To learn more about the published research and activities of the Alliance, read the articles below.
Cancer nanomedicines: closing the translational gap
A paper published in The Lancet that provides a collective view of the translational state of nanomedicines for cancer.
NCI Investment in Nanotechnology: Achievements and Challenges for the Future
A paper published in WIRE's Nanomedicine and Nanobiotechnology that provides an overview of NCIs investment in nanotechnology training and research, including a review of various nanotechnology programs supported by the NIH and NCI. This paper also discusses plans for future work with the nanotechnology community in the pursuit of innovative nanotechnology-based solutions to cancer.
Future Opportunities in Cancer Nanotechnology—NCI Strategic Workshop Report
March 1, 2014
The National Cancer Institute, which currently supports an array of research activities in cancer nanotechnology, convened a strategic workshop to explore the most promising directions and areas for future resource investment. The major discussion points, as well as the opportunities identified, were published in the journal Cancer Research.
Summary of Responses to the Request for Information
The National Cancer Institute Office of Cancer Nanotechnology Research published a summary of the responses to a request for information on the Directions and Needs for Cancer Nanotechnology Research and Development. The RFI sought to gain feedback, comments and ideas on the status and future of the field and the role NCI funding has played and should continue to play in the future.
NCI Alliance for Nanotechnology in Cancer Annual Bulletin
The NCI Alliance for Nanotechnology in Cancer published its 2013 issue of the annual bulletin summarizing the accomplishments of the program over the past year. The bulletin outlines the various ways the Alliance reaches the wider scientific community, as demonstrated by numerous news stories, perspective articles, and solicitations for community input, all focused on advancing the cancer nanotechnology field.
Biotargeted Nanomedicines for Cancer: Six Tenets Before You Begin Published in Nanomedicine
A paper published in the journal Nanomedicine, provides a brief summary of the most important nano-based tumor targeting systems and strategies, and discusses recent advances and future directions in the development of tumour-targeted nanomedicines.
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance Published in Clinical Cancer Research
The NCI Office of Cancer Nanotechnology Research published a paper in Clinical Cancer Research that discusses the future prospects of using nanotechnology in cancer applications and practices and methodologies used in the development and translation of nanotechnology-based therapeutics.
Kindling Translational Cancer Nanotechnology Research Published in Nanomedicine
A paper published in the journal Nanomedicine, provides an overview of the NCI Alliance for Nanotechnology in Cancer and features the Alliance's programs which are dedicated to supporting cancer nanomedicine research.
Nanotechnology-based Cancer Therapeutics—Promise and Challenge—Lessons Learned through the NCI Alliance for Nanotechnology in Cancer Published in Pharmaceutical Research
The NCI Office of Cancer Nanotechnology Research published a paper in Pharmaceutical Research that summarizes current developments in nanotechnology-based drug delivery and discusses the path forward in the context of research and development occurring within the NCI Alliance for Nanotechnology in Cancer.
Commentary on Nanomedicine in Cancer Therapy Published in IEEE Nanotechnology
The NCI Office of Cancer Nanotechnology Research published a paper in IEEE Nanotechnology, highlighting interesting research conducted by the NCI Alliance for Nanotechnology in Cancer investigators aimed at improving cancer diagnoses and treatment.
Alliance Achievements and Path Forward Published in WIREs Nanomedicine and Nanobiotechnology
June 8, 2010
A paper published in the journal WIREs Nanomedicine and Nanobiotechnology highlights Alliance achievements in demonstrating that multidisciplinary research catalyzes scientific developments and advances clinical translation in cancer nanotechnology. The paper also discusses goals for the next phase of the program.
Highlights from Alliance Workshops on Cancer Nanotechnology Published in Cancer Research
May 11, 2010
The Alliance conducted three strategic workshops focused on the use of nanotechnology in the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. Highlights from these workshops were published in the journal Cancer Research.
Highlights from 2009 Alliance PI Meeting Published in ACS Nano
February 23, 2010
Alliance research in the areas of in vitro diagnostics, targeted delivery of anticancer and contrast enhancement agents, and nanotherapeutics that was presented at the 2009 Principal Investigators’ Meeting in Manhattan Beach, CA, were published in ACS Nano.
Meeting Report from First Joint China-U.S. Symposium on Nanobiotechnology and Nanomedicine Published in Cancer Research
July 1, 2009
The first Joint China-U.S. Symposium on Nanobiotechnology and Nanomedicine was convened in October 2008, in Beijing, China. Participants shared experiences and exchanged information pertaining to the development of nanotechnology for medical use including the prevention, detection, and treatment of disease, and ensuring the safety of the general public and of personnel working in the field. The symposium also provided a platform for exploring the development of new research collaborations among top Chinese and American scientists.
Alliance Commentary on the Use of Nanotechnology to Improve Cancer Diagnosis Published in Expert Review of Molecular Diagnostics
May 1, 2006
A paper published in Expert Review of Molecular Diagnostics discusses why nanotechnology is in a unique position to transform cancer diagnostics and to produce a new generation of biosensors and medical imaging techniques with higher sensitivity and precision of recognition. In vitro and in vivo diagnostic applications of nanoparticles and other nanodevices are also discussed.